Vertex created an effective non-opioid painkiller. Hospitals, PBMs say they’d want real-world data before abandoning cheap opioids and NSAIDs

Market cap crosses $100B threshold; analysts see consistent growth as the big biotech continues to diversify beyond cystic fibrosis

Responding to a Government Accountability Office report on direct-to-consumer advertising of drugs, Sen. Dick Durbin (D-Ill.) and Sen. Chuck Grassley (R-Iowa) Thursday said they plan to reintroduce

How long-term data helped justify Revlimid, Genovya price increases to ICER where other drugs faltered